Expanding Veterans’ Access to Emerging Treatments Act

Referred to the Subcommittee on Health.

• Introduced in House Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

• Health Subcommittee
  House of Representatives · subcommittee of Veterans' Affairs Committee
• Veterans' Affairs Committee
  House of Representatives

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

• RK STRATEGIES, INC.
  for CLEARMIND MEDICINE, INC · British Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
• RK STRATEGIES, INC.
  for NEXALIN TECHNOLOGY INC. · Texas · 3rd Quarter 2026 (July 1 - Sep 30)
• DISABLED AMERICAN VETERANS
  for DISABLED AMERICAN VETERANS · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
• DISABLED AMERICAN VETERANS
  for DISABLED AMERICAN VETERANS · District of Columbia · 2nd Quarter 2026 (Apr 1 - June 30)
• RK STRATEGIES, INC.
  for CLEARMIND MEDICINE, INC · British Columbia · 2nd Quarter 2026 (Apr 1 - June 30)
• RK STRATEGIES, INC.
  for ADIAL PHARMACEUTICALS, INC. · Virginia · 2nd Quarter 2026 (Apr 1 - June 30)

Bodies those filers lobbied

• HOUSE OF REPRESENTATIVES
  13 filings
• SENATE
  13 filings
• Health & Human Services, Dept of (HHS)
  8 filings
• Defense, Dept of (DOD)
  7 filings
• Veterans Affairs, Dept of (VA)
  7 filings
• Labor, Dept of (DOL)
  3 filings
• Office of Management & Budget (OMB)
  3 filings
• Small Business Administration (SBA)
  3 filings

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.